These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 412648)

  • 1. Antimicrobial synergism in the therapy of gram-negative rod bacteremia.
    Anderson ET; Young LS; Hewitt WL
    Chemotherapy; 1978; 24(1):45-54. PubMed ID: 412648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory studies with tobramycin.
    Geddes AM; Goodall JA; Speirs CF; Gillett AP; Andrews J; Williams JD
    Chemotherapy; 1974; 20(4):245-56. PubMed ID: 4212996
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia.
    Weinstein RJ; Young LS; Hewitt WL
    J Lab Clin Med; 1975 Nov; 86(5):853-62. PubMed ID: 810533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
    Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). III. Secular changes in susceptibility].
    Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1990 Jun; 43(6):968-1136. PubMed ID: 2122041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal antibiotic concentrations of aminoglycosides and beta-lactam antibiotics for some gram-negative bacilli and gram-positive cocci.
    Lorian V; De Freitas CC
    J Infect Dis; 1979 May; 139(5):599-603. PubMed ID: 108345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy of vancomycin with penicillins and cephalosporins against pseudomonas, klebsiella, and serratia.
    Donabedian H; Andriole VT
    Yale J Biol Med; 1977; 50(2):165-76. PubMed ID: 408984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the antibacterial activity in vitro of various cephalosporins on different gram-negative bacterial species of recent clinical isolation].
    Piccolomini R; Di Sipio L; Ravagnan G
    Boll Soc Ital Biol Sper; 1980 Jan; 56(2):133-9. PubMed ID: 6776969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta-lactamine associations. In vitro synergism and clinical results].
    Acar JF
    Pathol Biol (Paris); 1971; 19(11):593-7. PubMed ID: 4997292
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
    Daschner FD; Steffens A; Langmaack H
    Chemotherapy; 1979; 25(5):282-5. PubMed ID: 113178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergy of cefamandole-tobramycin combinations.
    Valenti AJ; Siniscalchi AJ; Andriole VT
    Yale J Biol Med; 1977; 50(2):177-82. PubMed ID: 331694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of salicylates on antibiotic sensitivity.
    Esposito S; Noviello S; Maggiolo F
    J Chemother; 1990 Apr; 2(2):87-90. PubMed ID: 2163438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside antibiotics. V. The 4'-deoxybutirosins (Bu-1975C1 and C2), new aminoglycoside antibiotics of bacterial origin.
    Kawaguchi H; Tomita K; Hoshiya T; Miyaki T; Fujisawa K
    J Antibiot (Tokyo); 1974 Jun; 27(6):460-70. PubMed ID: 4211790
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combined effects of micronomicin and latamoxefi in vitro synergistic activities].
    Kurimoto T; Okachi R
    Jpn J Antibiot; 1983 Jul; 36(7):1599-603. PubMed ID: 6418932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside antibiotics. IV. BU-1709 E1 and E2, new aminoglycoside antibiotics related to the butirosins.
    Tsukiura H; Saito K; Kobaru S; Konishi M; Kawaguchi H
    J Antibiot (Tokyo); 1973 Jul; 26(7):386-8. PubMed ID: 4205652
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
    Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R plasmids coding for gentamicin, tobramycin, and carbenicillin resistance in Serratia, Klebsiella and Escherichia coli strains from a single clinical source.
    Knothe H; Kettner M; Kopsová D; Krcméry V
    Chemotherapy; 1977; 23(1):37-43. PubMed ID: 401718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-negative bacilli.
    Critchley IA; Sahm DF; Kelly LJ; Karlowsky JA
    Chemotherapy; 2003 May; 49(1-2):44-8. PubMed ID: 12714810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.